Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02842749
Recruitment Status : Active, not recruiting
First Posted : July 25, 2016
Last Update Posted : May 24, 2019
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2, 2024
Estimated Study Completion Date : December 2, 2024